Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Weight Loss 1Obesity 1Breast Neoplasms 1

Interventions

Cyclophosphamide 640Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 372Dexamethasone 351Doxorubicin 328Nivolumab 308Fluorouracil 286Capecitabine 260Prednisone 244Etoposide 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 210fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Has results × TOPS × Clear all
NCT04741802 2024-02-28

TOPS for African American Breast Cancer Survivors

Duke University

Phase NA Completed
26 enrolled 10 charts
BreastOther

Breast Neoplasms, Obesity, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡